{"id":"W4312886117","doi":"10.1136/ijgc-2022-esgo.278","title":"2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Endometrial cancer; Discontinuation; Clinical endpoint; Oncology; Microsatellite instability; Cancer; Cohort; Surrogate endpoint; Population; Tolerability; Progression-free survival; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Clinical trial; Phases of clinical research; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001058645,0.0006059449,0.001153457,0.000199364,0.0001622615,0.0007097878,0.0003407771,0.000596418,0.001190031],"category_scores_gemma":[0.0006912895,0.0002613791,0.00127336,0.0003384713,0.0002987874,0.0003934421,0.0003389402,0.001303538,0.0002937459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003655431,"about_ca_system_score_gemma":0.0003949677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005138096,"about_ca_topic_score_gemma":0.001752185,"domain_scores_codex":[0.9996579,0.0001768423,0.00001839416,0.00004349906,0.00004319649,0.00006034767],"domain_scores_gemma":[0.9996668,0.00006899624,0.0000979012,0.00004095243,0.0000232526,0.0001020729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6136545,0.003001367,0.2591671,0.001679503,0.0144902,0.0006081509,0.0001607173,0.003117215,0.01758512,0.0007409427,0.003525312,0.0822699],"study_design_scores_gemma":[0.1192582,0.07706762,0.7658443,0.0002635251,0.01540402,0.0006539486,0.0001948597,0.003160159,0.003372872,0.001198994,0.01348281,0.00009871311],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919161,0.005108193,0.0001420525,0.0002488172,0.0001075245,0.00009053772,0.0007542411,0.00001864388,0.001613892],"genre_scores_gemma":[0.9952727,0.001417449,0.0001732178,0.0003338646,0.0001393029,0.0001133892,0.00138341,0.00000733154,0.001159462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001190031,"threshold_uncertainty_score":0.005598664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01841590910658444,"score_gpt":0.3102841540036768,"score_spread":0.2918682448970923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}